Safety Considerations and Who Should Discuss GLP-1 with a Healthcare Provider GLP-1 agonists carry known risks: gastrointestinal side effects, pancreatitis risk in susceptible individuals, and thyroid concerns in some populations
Convergence of sepsis-associated encephalopathy pathogenesis onto microglia
PlexusDx tracks your progress and optimizes your dose to maximize your personal response
You dont crave junk and sugary food anymore, thanks to delicious GLP-1 gummies
MASLD/MAFLD, metabolic dysfunctionassociated steatotic liver disease/metabolic-associated fatty liver disease
As we have documented the tolerability of L-PAM+BSO when supported by autologous stem cell infusion in heavily pretreated relapsed and/or refractory neuroblastoma patients (NANT phase I study, NCT00005835, www.clinicaltrials.gov), using myeloablative L-PAM+BSO is clinically feasible